Market Tracker

12/11 1:40pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

18.65
BATS BZX Real-Time Price
As of 1:35pm ET
 +0.35 / +1.91%
Today’s Change
3.70
Today|||52-Week Range
24.45
+372.15%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close18.30
Today’s open18.65
Day’s range18.10 - 18.90
Volume23,387
Average volume (3 months)2,062,634
Market cap$1.1B
Dividend yield--
Data as of 1:35pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+40.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book7.92

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.43+1.26%
CLLSCellectis SA+0.13+0.50%
XNCRXencor Inc+0.02+0.09%
DERMDermira Inc+0.17+0.65%
Data as of 1:38pm ET, 12/11/2017

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts